Advertisement
Australia markets close in 5 hours 32 minutes
  • ALL ORDS

    7,965.00
    +27.10 (+0.34%)
     
  • ASX 200

    7,711.60
    +28.10 (+0.37%)
     
  • AUD/USD

    0.6494
    +0.0005 (+0.08%)
     
  • OIL

    83.46
    +0.10 (+0.12%)
     
  • GOLD

    2,336.10
    -6.00 (-0.26%)
     
  • Bitcoin AUD

    102,684.76
    -455.37 (-0.44%)
     
  • CMC Crypto 200

    1,430.44
    +15.68 (+1.11%)
     
  • AUD/EUR

    0.6060
    +0.0004 (+0.07%)
     
  • AUD/NZD

    1.0926
    -0.0004 (-0.04%)
     
  • NZX 50

    11,861.03
    +57.75 (+0.49%)
     
  • NASDAQ

    17,471.47
    +260.59 (+1.51%)
     
  • FTSE

    8,044.81
    +20.94 (+0.26%)
     
  • Dow Jones

    38,503.69
    +263.71 (+0.69%)
     
  • DAX

    18,137.65
    +276.85 (+1.55%)
     
  • Hang Seng

    16,828.93
    +317.24 (+1.92%)
     
  • NIKKEI 225

    38,204.34
    +652.18 (+1.74%)
     

Company News for Aug 18, 2022

  • Target Corp’s TGT shares fell 2.7% after the company reported second-quarter fiscal 2022 adjusted earnings per share of $0.39, missing the Zacks Consensus Estimate of $0.71.

  • Shares of Lowe's Companies Inc. LOW rose 0.6% after reporting second-quarter fiscal 2022 adjusted earnings per share of $4.67, outpacing the Zacks Consensus Estimate of $4.63.

  • Shares of The TJX Companies Inc. TJX gained 2.8% after posting  second-quarter fiscal 2023 adjusted earnings per share of $0.69, surpassing the Zacks Consensus Estimate of $0.67.

  • Agilent Technologies Inc.’s A shares jumped 7.2% after the company posted third-quarter fiscal 2022 adjusted earnings per share of $1.34, beating the Zacks Consensus Estimate of $1.20.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Target Corporation (TGT) : Free Stock Analysis Report
 
The TJX Companies, Inc. (TJX) : Free Stock Analysis Report
 
Lowe's Companies, Inc. (LOW) : Free Stock Analysis Report
 
Agilent Technologies, Inc. (A) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research